Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1

Status

Completed 21Unknown 10Terminated 7Recruiting 7Active not recruiting 4Not yet recruiting 3Withdrawn 2

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gynecologic 3Gastrointestinal 2Endocrine 1

Conditions

Peritoneal Neoplasms 2Stomach Neoplasms 1Ovarian Neoplasms 1Fallopian Tube Neoplasms 1Colorectal Neoplasms 1Carcinoma, Ovarian Epithelial 1Appendiceal Neoplasms 1Adrenocortical Carcinoma 1

Interventions

pembrolizumab 223Cyclophosphamide 192Radiotherapy 184Nivolumab 180Carboplatin 153Cisplatin 114Paclitaxel 112Dexamethasone 111Radiosurgery 103Magnetic Resonance Spectroscopy 97Surveys and Questionnaires 90Ipilimumab 81Doxorubicin 79Lenalidomide 76Rituximab 75durvalumab 74Radiation 73atezolizumab 72venetoclax 68fludarabine 68Gemcitabine 68Standard of Care 67Specimen Handling 65Etoposide 64Capecitabine 64Bevacizumab 62Oxaliplatin 59Docetaxel 58Biopsy 58Radiotherapy, Intensity-Modulated 56

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Active not recruiting × OTHER × Cytoreduction Surgical Procedures × Clear all
NCT03127774 2026-05-06

Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical Carcinoma

Columbia University

Phase 2 Active not recruiting
30 enrolled
EndocrineGynecologic

Peritoneal Neoplasms, Adrenocortical Carcinoma

NCT01815359 2026-02-05

ICARuS

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
292 enrolled
Gastrointestinal

Appendiceal Neoplasms, Colorectal Neoplasms

NCT03348150 2025-07-17

PERISCOPEII

The Netherlands Cancer Institute

Phase 3 Active not recruiting
102 enrolled
GastrointestinalGynecologic

Peritoneal Neoplasms, Stomach Neoplasms

NCT02124421 2024-11-19

CRS/HIPEC

Mercy Medical Center

Phase 2 Active not recruiting
32 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡